EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Doxycycline induces mitochondrial dysfunction in aortic smooth muscle cells

Carmen Yap, Shaynah Wanga, Rob C I Wüst, Bram W van Os, Maud M E Pijls, Sofie Keijzer, Eva van Zanten, David R Koolbergen, Antoine H G Driessen, Ron Balm, Kak Khee Yeung, Carlie J M de Vries und 3 weitere

Vascular Pharmacology · 2024-03 · 154 · 107279

DOI: 10.1016/j.vph.2024.107279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Pharmacology, 2024-03. Verfasst von Carmen Yap und 14 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC location University of Amsterdam, Medical Biochemistry, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Cardiovascular Sciences, …. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Mitochondrial Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Zeldzame Ziekten Fonds, Amsterdam Cardiovascular Sciences, Netherlands Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antibiotic doxycycline is known to inhibit inflammation and was therefore considered as a therapeutic to prevent abdominal aortic aneurysm (AAA) growth. Yet mitochondrial dysfunction is a key-characteristic of clinical AAA disease. We hypothesize that doxycycline impairs mitochondrial function in the aorta and aortic smooth muscle cells (SMCs). Doxycycline induced mitonuclear imbalance, reduced proliferation and diminished expression of typical contractile smooth muscle cell (SMC) proteins. To understand the underlying mechanism, we studied krüppel-like factor 4 (KLF4). The expression of this transcription factor was enhanced in SMCs after doxycycline treatment. Knockdown of KLF4, however, did not affect the doxycycline-induced SMC phenotypic changes. Then we used the bioenergetics drug elamipretide (SS-31). Doxycycline-induced loss of SMC contractility markers was not rescued, but mitochondrial genes and mitochondrial connectivity improved upon elamipretide. Thus while doxycycline is anti-inflammatory, it also induces mitochondrial dysfunction in aortic SMCs and causes SMC phenotypic switching, potentially contributing to aortic aneurysm pathology. The drug elamipretide helps mitigate the harmful effects of doxycycline on mitochondrial function in aortic SMC, and may be of interest for treatment of aneurysm diseases with pre-existing mitochondrial dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, AbdominalMitochondrial DiseasesHumansDoxycyclineAortaMyocytes, Smooth Muscle

Stichwörter der Autor:innen

Aortic aneurysmCellular phenotypeElamipretide (SS-31)MetabolismMitochondriaSmooth muscle cell

Substanzen

Doxycycline

Autor:innen und Institutionen

  • Amsterdam UMC location University of Amsterdam, Medical Biochemistry, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Amsterdam UMC location University of Amsterdam, Medical Biochemistry, Meibergdreef 9, Amsterdam, the Netherlands; Amsterdam UMC location University of Amsterdam, Cardiology, Meibergdreef 9, Amsterdam, the Netherlands.
  • Amsterdam UMC location Vrije Universiteit Amsterdam, Behavioural and Movement Sciences, Myology, Boelelaan 1117, Amsterdam, the Netherlands.
  • Amsterdam UMC location University of Amsterdam, Medical Biochemistry, Meibergdreef 9, Amsterdam, the Netherlands.
  • Amsterdam UMC location University of Amsterdam, Cardiothoracic Surgery, Meibergdreef 9, Amsterdam, the Netherlands.
  • Amsterdam UMC location University of Amsterdam, Vascular Surgery, Meibergdreef 9, Amsterdam, the Netherlands.

Förderung

  • Stichting Zeldzame Ziekten Fonds
  • Amsterdam Cardiovascular Sciences
  • Netherlands Heart Foundation

Zitieren

APA

Yap, C., Wanga, S., Wüst, R. C. I., van Os, B. W., Pijls, M. M. E., Keijzer, S., van Zanten, E., Koolbergen, D. R., Driessen, A. H. G., Balm, R., Yeung, K. K., de Vries, C. J. M., Houtkooper, R. H., Lindeman, J. H. N., & de Waard, V. (2024). Doxycycline induces mitochondrial dysfunction in aortic smooth muscle cells. Vascular Pharmacology, 154, 107279. https://doi.org/10.1016/j.vph.2024.107279

Vancouver

Yap C, Wanga S, Wüst RCI, van Os BW, Pijls MME, Keijzer S, et al. Doxycycline induces mitochondrial dysfunction in aortic smooth muscle cells. Vascular Pharmacology. 2024;154:107279. doi:10.1016/j.vph.2024.107279

BibTeX
@article{Yap2024,
  author = {Yap, Carmen and Wanga, Shaynah and Wüst, Rob C I and van Os, Bram W and Pijls, Maud M E and Keijzer, Sofie and van Zanten, Eva and Koolbergen, David R and Driessen, Antoine H G and Balm, Ron and Yeung, Kak Khee and de Vries, Carlie J M and Houtkooper, Riekelt H and Lindeman, Jan H N and de Waard, Vivian},
  title = {Doxycycline induces mitochondrial dysfunction in aortic smooth muscle cells},
  journal = {Vascular Pharmacology},
  year = {2024},
  volume = {154},
  pages = {107279},
  doi = {10.1016/j.vph.2024.107279}
}
Kostenlos starten →